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More than one billion pounds of pesticides
are used annually in the United States, three-
quarters of which are used in agriculture
(Donaldson et al. 2002). Recent biological
monitoring studies indicate that pesticide
exposures are widespread in the U.S. popula-
tion, including to pregnant women and chil-
dren [Barr et al. 2004; Berkowitz et al. 2003;
Bradman et al. 2005; Centers for Disease
Control and Prevention (CDC) 2006; Fenske
et al. 2000; Whyatt et al. 2003].
There is evidence that fetuses can be
exposed to pesticides. Pesticides pass through
the blood–brain barrier and placenta and have
also been found in amniotic ﬂuid (Bradman
et al. 2003). In addition, relative to their body
size, young children may receive greater expo-
sure than adults, because they eat, drink, and
breathe more per unit of body weight
(National Research Council 1993). They are
closer to the floor and surfaces where pesti-
cides may settle, and have extensive hand-to-
mouth contact (Zartarian et al. 2000). 
Fetuses and young children may also be
more susceptible to potential neurotoxic
effects of pesticides, because their brains are
developing rapidly (Rice and Barone 2000).
Organophosphates (OPs) and carbamates break
down the enzyme acetylcholinesterase (AChE),
already lower during pregnancy (Evans et al.
1988), allowing acetylycholine to build up in
the neuronal junction. AChE inhibition dis-
rupts cell replication and differentiation, synap-
togenesis, and axonogenesis (Bigbee et al. 2000;
Lauder and Schambra 1999). It is likely that
pesticides also act through noncholinergic
mechanisms involving alterations in expression
and function of nuclear transcription factors
(Dam et al. 2003). Recent studies have shown
that fetuses and young children have lower-
than-adult levels of detoxifying enzymes
(paraoxonase or chlorpyrifos-oxonase) that
deactivate OPs (Furlong et al. 2006; Holland
et al. 2006), suggesting that they may be more
vulnerable to these exposures.
Numerous animal studies have demon-
strated that in utero or early exposure to OP
pesticides affect neurodevelopment (Eskenazi
et al. 1999). Although acute poisonings can
cause neurologic impairment in children
(Zwiener and Ginsburg 1988), few studies
have assessed neurodevelopment of young
children after low-level OP pesticide exposure
(Grandjean et al. 2006; Guillette et al. 1998;
Rauh et al. 2006; Ruckart et al. 2004; Young
et al. 2005), and even fewer have done so
using biomarkers of exposure. In an ecologic
study (Guillette et al. 1998), 33 Yaqui
Mexican 4- to 5-year-olds living in a valley
where OPs, organochlorines (OC), and other
pesticides were used were compared with 17
children living where no pesticides were used.
Exposed children showed lower performance
in gross motor, eye–hand coordination, draw-
a-person, and delayed recall. In a study of 2-
to 12-year-olds living in Mississippi and Ohio
where methyl parathion was illegally sprayed
in homes, exposed children showed decreased
selective attention, delayed verbal memory,
poorer motor skills, and behavioral problems;
yet the authors deemed the results inconclu-
sive because of inconsistent findings across
sites (Ruckart et al. 2004). A recent investiga-
tion in 72 6- to 9-year-old Ecuadoreans found
that those whose mothers worked in ﬂoricul-
ture during pregnancy scored lower on the
Stanford-Binet Copying Test than unexposed
children. Concurrent exposure to OPs, as
assessed by the children’s urinary dialkyl phos-
phate (DAP) metabolite levels, was associated
with increased reaction time, but not with
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BACKGROUND: Organophosphate (OP) pesticides are widely used in agriculture and homes. Animal
studies suggest that even moderate doses are neurodevelopmental toxicants, but there are few studies
in humans.
OBJECTIVES: We investigated the relationship of prenatal and child OP urinary metabolite levels
with children’s neurodevelopment. 
METHODS: Participating children were from a longitudinal birth cohort of primarily Latino farm-
worker families in California. We measured six nonspeciﬁc dialkylphosphate (DAP) metabolites in
maternal and child urine as well as metabolites specific to malathion (MDA) and chlorpyrifos
(TCPy) in maternal urine. We examined their association with children’s performance at 6 (n =
396), 12 (n = 395), and 24 (n = 372) months of age on the Bayley Scales of Infant Development
[Mental Development (MDI) and Psychomotor Development (PDI) Indices] and mother’s report
on the Child Behavior Checklist (CBCL) (n = 356). 
RESULTS: Generally, pregnancy DAP levels were negatively associated with MDI, but child measures
were positively associated. At 24 months of age, these associations reached statistical signiﬁcance [per
10-fold increase in prenatal DAPs: β = –3.5 points; 95% conﬁdence interval (CI), –6.6 to –0.5; child
DAPs: β = 2.4 points; 95% CI, 0.5 to 4.2]. Neither prenatal nor child DAPs were associated with
PDI or CBCL attention problems, but both prenatal and postnatal DAPs were associated with risk
of pervasive developmental disorder [per 10-fold increase in prenatal DAPs: odds ratio (OR) = 2.3,
p = 0.05; child DAPs OR = 1.7, p = 0.04]. MDA and TCPy were not associated with any outcome.
CONCLUSIONS: We report adverse associations of prenatal DAPs with mental development and per-
vasive developmental problems at 24 months of age. Results should be interpreted with caution
given the observed positive relationship with postnatal DAPs.
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http://dx.doi.org/ [Online 4 January 2007]other domains of neurobehavior (Grandjean
et al. 2006). Recently, Rauh et al. (2006) exam-
ined the relationship of maternal blood levels of
chlorpyrifos, a diethyl phosphate pesticide, dur-
ing pregnancy and performance on the Bayley
Scales of Infant Development of 254 inner-city
minority children through 3 years of age.
Three-year-olds with high prenatal chlorpyrifos
showed signiﬁcantly more delays in psychomo-
tor and mental development, and mothers
reported more attention problems and symp-
toms of pervasive developmental problems. 
In the present study, we investigated
neurodevelopment and behavior in a cohort of
children from primarily Latino, farmworker
families living in the Salinas Valley of
California. We previously reported that mater-
nal prenatal DAP urinary metabolite levels in
this cohort were signiﬁcantly higher than for
the general U.S. population sampled in the
National Health and Nutrition Examination
Survey (NHANES) survey (Bradman et al.
2005; CDC 2006). Additionally, we found
prenatal DAPs to be associated with shortened
gestational duration (Eskenazi et al. 2004) and
abnormal neonatal reﬂexes, but not other clus-
ters, on the Brazelton Neonatal Behavioral
Assessment Scale (Young et al. 2005). We
now present findings on the relationship of
maternal prenatal and child DAP levels with
performance on the Bayley Scales through
2 years of age and with maternal reports of
behavior on the Child Behavior Checklist
(CBCL) at 2 years of age.
Materials and Methods
Participants and recruitment. The Center for
the Health Assessment of Mothers and
Children of Salinas (CHAMACOS) of the
Center for Children’s Environmental Health
Research at the University of California,
Berkeley, sponsors a prospective cohort study
of the association of pesticides and other envi-
ronmental exposures on the health of preg-
nant women and their children living in the
agricultural Salinas Valley, California.
Detailed methods for the CHAMACOS
study have been described elsewhere (Eskenazi
et al. 2004, 2006). Pregnant women were
screened for eligibility between October 1999
and 2000. Eligible women were ≥ 18 years
old, < 20 weeks gestation, Spanish- or English-
speaking, eligible for Medi-Cal, receiving pre-
natal care at one of six community clinics
serving primarily farmworker families, and
planning to deliver at Natividad Medical
Center. All participating women gave written
informed consent. The institutional review
board at University of California, Berkeley,
approved the study.
We followed 531 women to delivery of a
liveborn, surviving neonate. We excluded
from analyses children who lacked a neuro-
developmental assessment (n = 71), who did
not have prenatal and relevant concurrent
DAP metabolites measured (n = 3), were not
singletons (n = 8), or had a medical condition
which could affect assessment (n = 3; Down
syndrome, deafness, hydrocephalus). We
excluded Bayley results if raw scores were too
low for standardization (n = 3, 1, and 1 for
6-, 12-, and 24-month assessments, respec-
tively), or if assessed by a psychometrician
who had completed too few for statistical
adjustment (n = 4 at 6 months). Bayley analy-
ses included 396 infants at 6 months, 395 at
12 months, and 372 at 24 months. In a few
cases, a child had a valid score for only the
Bayley Mental Developmental Index (MDI)
or Psychomotor Developmental Index (PDI)
(Bayley 1993). A total of 356 mothers com-
pleted the CBCL at the 24-month visit. 
Maternal interviews and assessments.
Women were interviewed twice during preg-
nancy (mean = 14.0 and 26.6 weeks gestation),
shortly after delivery, and when children were
6, 12, and 24 months old. Interviews were
conducted in Spanish or English by bilingual,
bicultural interviewers. Mothers were adminis-
tered the Peabody Picture Vocabulary Test
(PPVT) (Dunn and Dunn 1981) to assess
scholastic abilities at the 6-month visit, and the
Center for Epidemiologic Studies Depression
Scale (CES-D) (Radloff 1977) at the
12-month visit. The Infant-Toddler HOME
(Home Observation for Measurement of the
Environment) (Caldwell and Bradley 1984)
instrument was completed at 6 and 12 months
of age, and 32 of 45 items were completed at
24 months. Prenatal and delivery medical
records were abstracted by a registered nurse.
Neurodevelopmental and behavioral out-
comes. Bayley Scales of Infant Development.
The Bayley Scales of Infant Development,
Second Edition (Bayley 1993) assess the devel-
opmental functioning of infants and young
children. The MDI characterizes a variety of
cognitive abilities, and the PDI characterizes
large muscle and ﬁne motor coordination. Both
scales were administered in Spanish and/or
English by psychometricians blind to exposure.
Psychometricians were trained using standard-
ized protocols and were supervised for quality
assurance by a clinical neuropsychologist.
Assessments were performed in a private room
at the CHAMACOS research office or in a
recreation vehicle (RV) modiﬁed to be a mobile
testing facility. Children were assessed on aver-
age (mean ± SD) at 6.6 ± 1.1 months, 12.8 ±
1.6 months, and 24.6 ± 1.1 months. Each scale
is standardized by age to mean = 100 and SD =
15. Scores > 1 SD below the mean (i.e., < 85)
indicate possible developmental delay. 
CBCL. The 99-item CBCL for Ages
1.5–5 (Achenbach and Rescorla 2000) was
administered to mothers to assess 2-year-
olds’ emotional/behavioral problems and
competencies. The CBCL has been widely
used in cross-cultural research and collects data
on a range of behavior problems, yielding
scores for several syndrome scales and five
scales designed to be consistent with Diagnostic
and Statistical Manual of Mental Disorders
(DSM) diagnoses (American Psychiatric
Association 2000). A priori, we chose three
scales to examine in relation to DAPs based on
the animal literature (Eskenazi et al. 1999): the
Attention Problems syndrome scale, which
includes such items as “can’t concentrate” and
“can’t sit still”; the DSM-oriented Attention-
Deﬁcit/Hyperactivity Disorder (ADHD) scale,
which additionally includes such items as “gets
into everything”; and the DSM-oriented
Pervasive Developmental Disorder (PDD)
scale, which includes such items as “avoids eye
contact,” “rocks head, body,” and “unrespon-
sive to affection,” which are “rated as very con-
sistent with Asperger’s Disorder and Autistic
Disorder” (Achenbach and Rescorla 2000). A
score considered of “clinical” significance is
> 98th percentile of the national normative
sample, and of “borderline” clinical signifi-
cance is > 93rd percentile. 
Pesticide exposure measurement. We meas-
ured six nonspeciﬁc OP DAP metabolites in
maternal and child urine: three dimethyl (DM)
phosphate metabolites (dimethylphosphate,
dimethylthiophosphate, dimethyldithiophos-
phate); and three diethyl (DE) phosphate
metabolites (diethylphosphate, diethylthio-
phosphate, and diethyldithiophosphate)
(Bradman et al. 2005). These six metabolites
represent the by-products of approximately
80% of OPs used in the Salinas Valley.
Maternal urine was also analyzed for metabo-
lites specific to malathion [malathion dicar-
boxylic acid (MDA)], and chlorpyrifos
[3,5,6-trichloro-2-pyridinol (TCPy)] (Olsson
et al. 2003). MDA levels were missing for
91 women because of analytical problems.
Values below the limit of detection (LOD)
were assigned a value of LOD/(√2). Urinary
creatinine concentrations were determined
using a commercially available diagnostic
enzyme method (Vitros CREA slides; Ortho
Clinical Diagnostics, Raritan, NJ). 
Urine specimens were usually collected at
the time of interview and were aliquoted and
stored at –80°C until shipment on dry ice to
the CDC (Atlanta, GA). DAPs metabolites
were measured using gas chromatography-
tandem mass spectrometry and quantified
using isotope dilution calibration (Bravo et al.
2002). Details of urine collection, analysis and
quality control procedures, including detec-
tion limits and use of blanks and spikes, are
described elsewhere (Bradman et al. 2005).
Serum levels of dichlorodiphenyl-
trichloroethane (DDT) and dichlorodiphenyl-
dichloroethylene (DDE) (p,p′-DDT, o,p′-DDT,
p,p′-DDE), β-hexachlorocyclohexane, hexa-
chlorobenzene, and polychlorinated biphenyls
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samples using gas chromatography-high reso-
lution mass spectrometry methods (Barr et al.
2003). OC and PCB measures were lipid-
adjusted. Total PCBs were derived from
serum levels of congeners 138, 153, and 180
(Needham et al. 2005). Lead was measured in
cord blood using graphite furnace atomic
absorption spectrophotometry.
Data analysis. Nonspeciﬁc DAP metabo-
lites (nanomoles per liter) were summed and
transformed to the log10 scale. We created
“pregnancy” DEs, DMs, and total DAP values
by averaging the two log-transformed preg-
nancy measures. The two pregnancy total DAP
measurements were correlated (r = 0.14, p =
0.005) and did not signiﬁcantly differ (paired
t-test = –0.28, p = 0.78). For 29 women, only
one DAP measurement was available. Prenatal
and postnatal DAP measures were uncorre-
lated, so we placed both exposures into a single
model for each outcome. Coefficients were
similar to those in models containing either
prenatal or postnatal exposures alone. Because
a large proportion of women had nonde-
tectable levels of MDA and TCPy, we catego-
rized levels into three groups for each
metabolite: < LOD for both pregnancy meas-
urements, and for those with at least one
detectable level, subdivided below and above
the median of the average pregnancy level. 
To assess the relationship between metabo-
lite levels and Bayley performance, we con-
structed separate multiple regression models
for MDI and PDI at each of the three time
points: 6, 12, and 24 months. We evaluated
MDI and PDI continuously using linear
regression. We included the same covariates in
all Bayley models. Covariates were selected for
these analyses if they were related to conditions
of testing [i.e., psychometrician (n = 4), loca-
tion (ofﬁce or RV), exact age at assessment];
related to neurodevelopment in the literature
and associated (p < 0.10) with most outcomes
[i.e. sex, breast-feeding duration (months),
HOME score (continuous), and household
income]; or consistently related to neurodevel-
opment in the literature even if not in our data
[i.e., parity and maternal PPVT (continuous)].
We classified household income as above or
below poverty by comparing total household
income to the federal poverty threshold for a
household of that size (U.S. Census Bureau
2000). In addition to the variables we
included, we examined the potential con-
founding effects of several other variables sug-
gested by the literature (i.e., maternal age,
education, depressive symptoms, active/passive
smoking exposure during pregnancy, regular
alcohol use during pregnancy, marital status,
father’s presence in home, housing density,
maternal work status, ≥ 15 hours out-of-home
childcare/week), but they did not markedly
alter the observed associations. For simplicity,
the same set of covariates was used for CBCL
models with three exceptions: maternal depres-
sion, found to be important (p < 0.10), was
added, and psychometrician and assessment
location were dropped, because scores were
based on maternal report. Covariates in ﬁnal
models were categorized as noted in Table 1,
unless otherwise speciﬁed above. To preserve
the size of the analytic population, each miss-
ing covariate value was imputed by randomly
selecting a value from participants with non-
missing values. Maternal depression had the
largest percentage of values requiring imputa-
tion (5%). Of remaining covariates, between
0% and 1.8% of values were imputed. 
In secondary analyses, we controlled for
some factors potentially on the causal pathway
(birth weight, gestational age, abnormal
reﬂexes) and re-ran models excluding low birth
weight and preterm infants. We also considered
whether controlling for other suspected neuro-
toxicants (i.e., PCBs, lead, and DDT) and
other high-level exposures in our population
(i.e., β-hexachlorocyclohexane and hexa-
chlorobenzene) (Fenster et al. 2006) altered our
results for DAPs in the subsample with both
DAPs and the other chemical. Furthermore, we
examined interactions between child DAPs and
child sex and, because we previously observed
an association with maternal DDT and
24-month MDI (Eskenazi et al. 2006),
between maternal DAPs and DDT. Finally, we
re-ran models using log-transformed creatinine-
adjusted metabolites for comparative purposes. 
In addition, we performed longitudinal
data analyses [generalized estimating equations
(GEE)] of the relationship between DAPs and
Bayley scores, which produced similar find-
ings. These GEE models included indicators
for age at assessment and interaction terms for
most independent variables and age. We
obtained a minor increase in precision when
the effects of some potential confounders were
assumed constant over time. In addition,
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Table 1. Demographic characteristics (n = 447) of CHAMACOS study population, Salinas Valley, California,
2000–2001 [no. (%)]. 
Characteristic Baseline 6 months 12 months 24 months
Child sex 
Female 226  (50.6)
Male 221 (49.4)
Maternal age (years)
18–24 199 (44.5)
25–29 139 (31.1)
30–34 73 (16.3)
≥ 35 36 (8.1)
Parity
0 144 (32.2)
≥ 1 303 (67.8)
Maternal education
< 6th grade  197 (44.1)
7–12th grade 163 (36.5)
Completed high school 87 (19.5)
Maternal country of birth
Mexico 380 (85.0)
United States 59 (13.2)
Other 8 (1.8)
Married or living as married
Yes 366 (81.9)
No 81 (18.1)
Alcohol use during pregnancy 
Yes 4 (0.9)
No 423 (99.1)
Smoking during pregnancy 
Yes 23 (5.2)
Lived with smoker 37 (8.3)
No 387 (86.6)
Maternal depressive symptioms (CES-D ≥ 16)
Yes 203 (50.9)
No 196 (49.1)
Breast-feeding at time of assessmenta
Yes 208 (51.5) 124 (30.6)  30 (7.9)
No 196 (48.5) 281 (69.4) 350 (92.1)
Household income above poverty thresholda
Yes 161 (38.0) 115 (28.8) 125 (33.8) 144 (40.9)
No 263 (62.0) 284 (71.2) 245 (66.2) 208 (59.1)
HOME score (points)a,b
0–25 34 (7.6) 1 (0.2)
26–36 360 (80.5) 232 (55.9)
> 36 53 (11.9) 182 (43.9)
Percentages represent percent of known values. 
aValues at 6, 12, and 24 months of age are limited to population that had a Bayley assessment performed at that time.
bHOME score at 24 months of age is not complete.assuming a single effect of DAPs over time
also produced small increases in precision of
the relevant regression coefﬁcient estimators,
but again the gains were slight. Thus, we only
present the results from the cross-sectional
analyses for ease of understanding. 
Results
Women were primarily young and parous,
and relatively few had completed high school
(Table 1). Most mothers were born in Mexico
and spoke Spanish (89%), and 23% had been
in the United States ≤ 1 year at enrollment.
Nearly all (92%) lived with the child’s father,
and two-thirds of families lived below the fed-
eral poverty threshold (U.S. Census Bureau
2000). Most women (82%) lived with one or
more farmworkers and 43% worked in agri-
culture themselves during pregnancy. Almost
no mothers consumed alcohol regularly dur-
ing pregnancy, and few smoked or lived with
a smoker. Half had symptoms of depression
1 year postpartum. The average maternal
PPVT score was in the low normal range,
averaging 86 ± 21. 
One-third of children were first-born
(Table 1). Almost all were initially breast-fed
(96.6%), half for ≥ 6 months, and 29% still
breast-fed at 12 months of age. Few children
lived in home environments considered to be
of low quality in terms of stimulation and
interaction (HOME scores < 26) at 6 (8%)
and 12 (< 1%) months of age. 
The geometric mean (GM) of pregnancy
DAPs was 114.9 nmol/L (Table 2). Child lev-
els increased with age, with total DAPs averag-
ing 45.5, 59.5, and 70.9 nmol/L at 6, 12, and
24 months of age, respectively. Maternal DAPs
were uncorrelated with child DAPs (r = 0.04
with each age, p = 0.40 to 0.47); The 12- and
24-month DAPs were correlated (r = 0.20, p <
0.001) but neither was correlated with
6-month DAPs. DMs were similarly corre-
lated, but there was no correlation of DE mea-
surements across ages. However, at any given
age, the DEs and DMs were signiﬁcantly cor-
related (r = 0.28–0.50, p < 0.001). 
As shown in Table 2, < 40% of MDA levels
were above the LOD; the median detectable
level was around 1 µg/L. Most (91%) mothers
had detectable serum TCPy, with a median
level around 4 µg/L.
At 6, 12, and 24 months of age, respec-
tively, Bayley PDI scores (mean ± SD) were
96.4 ± 10.6, 106.0 ± 12.6, and 97.5 ± 10.6,
and MDI scores were 95.7 ± 7.0, 100.6 ± 8.9,
and 85.9 ± 11.8 (Table 3). The proportion of
MDI scores < 85 increased dramatically at
24 months with 50% < 85 relative to 3–4% on
earlier assessments. On the CBCL, more chil-
dren scored in the clinical range on the DSM-
oriented pervasive developmental disorder scale
(14.4%) than the national reference sample
(≤ 3%) (binomial test p < 0.0001), although
similar to the expected proportion of children
scored in the clinical range on the attention
problems syndrome (2.0%) and ADHD
(3.3%) scales (Table 3). 
Table 4 presents the change [and 95%
conﬁdence intervals (CIs)] in PDI and MDI
scores associated with a 10-fold increase in
metabolites, controlling for covariates. Results
were similar in unadjusted models. We did not
observe any statistically signiﬁcant associations
between metabolite levels and PDI at any age.
We observed an overall pattern of negative
associations between pregnancy metabolites
and MDI, and positive associations between
concurrent child metabolites and MDI, which
were not statistically significant until the
24-month assessment. Specifically, for every
10-fold increase in pregnancy DAPs, we found
a 3.5 point decrease in the 24-month-olds’
MDI (95% CI, –6.6 to –0.5; p = 0.02); how-
ever, for every 10-fold increase in the DAPs at
24 months, we observed a 2.4 point increase in
MDI (95% CI, 0.5 to 4.2; p = 0.01). We
attribute the associations with total DAPs
largely to the DM metabolites, which indicated
a similar pattern of results. 
Table 5 summarizes multiple regression
results for CBCL outcomes. Because of small
numbers (Table 3), we used less conservative
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Table 3. Neurodevelopmental scale measures at 6, 12, and 24 months of age and neurobehavioral out-
comes at 24 months of age (CHAMACOS Study, Salinas Valley, CA, 2000–2003).
Developmental/behavioral assessment  No. Mean ± SD No. (%) with problema
Bayley Scales of Infant Development 
MDI
6 months 395 95.7 ± 7.0 17 (4.3)
12 months 393 100.6 ± 8.9 13 (3.3)
24 months 369 85.9 ± 11.8 184 (49.9)
PDI
6 months 396 96.4 ± 10.6 51 (12.9)
12 months 392 106.0 ± 12.6 12 (3.1)
24 months 371 97.5 ± 10.6 56 (15.1)
CBCL
Empirically based scales
Attention problems syndrome
Clinical (> 97th percentile) 356 — 7 (2.0)
Borderlineb (> 93rd percentile) 356 — 30 (8.4)
DSM-oriented scales
ADHD
Clinical (> 97th percentile) 356 — 10 (2.8)
Borderlineb (> 93rd percentile) 356 — 34 (9.6)
PDD
Clinicalb (> 97th percentile) 355 — 51 (14.4)
Borderline (> 93rd percentile) 355 — 105 (29.6)
aFor Bayley scales, “problem” is deﬁned as scoring more than one standard deviation below the mean, i.e., < 85. bCBCL
category used for regression models. “Clinical” is a subset of “borderline.”
Table 2. Urinary DAP metabolite measurements in mothers and children and pesticide-specific metabolites (MDA and TCPy) in mothers (CHAMACOS Study,
Salinas Valley, CA, 2000–2003).
DAPs (nmol/L)a,b Pesticide-speciﬁc metabolites (µg/L)a
Total DAPs  Total DMs  Total DEs  MDAc TCPyc
No. GM (95% CI) GM (95% CI)  GM (95% CI) Detectd Mediane Detectd Mediane
Maternal
1st pregnancy 442 113.5 (100.5–128.2) 83.7 (73.2–95.7)  16.1 (14.6–17.8) 33% 1.03 71% 3.76
2nd pregnancy 419 116.9 (106.2–128.7) 78.4 (70.3–87.6) 20.9 (18.6–23.5) 25% 0.96 82% 4.60
Averagef 445 114.9 (105.7–125.0) 81.5 (74.3–89.5) 18.1 (16.7–19.7) 39%g 0.82g 91%g 3.54g
Child
6 months 405 45.5 (39.6–52.3) 23.8 (20.4–27.8) 10.6 (8.9–11.9) — —
12 months 394 59.5 (51.7–68.5) 32.9 (27.8–38.9) 15.2 (13.5–17.2) — —
24 months 373 70.9 (61.4–81.9) 48.6 (41.8–56.6) 10.5 (8.8–12.6) — —
CI, conﬁdence interval. 
aUrinary metabolites, not adjusted for creatinine. bMeasurements below the LOD were assigned a value of LOD/√2. cn = 356 for pesticide-speciﬁc metabolites. dPercent above the LOD;
for average pregnancy, this represents percentage with at least one of two measures above the limit of detection. eMedian values for those with at least one measurement above the
LOD. fAverage of baseline and 26-week maternal pregnancy measures. gClassiﬁed as below the LOD if both pregnancy values are below the LOD. If one value is below the LOD, a value
of LOD/√2 is substituted for below the LOD value before averaging.“borderline” cut points for attention-related
outcomes. We did not observe any signiﬁcant
associations for these two scales with any
DAPs measurement. The only covariate we
found to be significantly related to risk of
attention problems and ADHD was maternal
depression: Mothers who reported depressive
symptomatology 12 months postpartum had
nearly 3-fold odds for reporting that their 2-
year-old had attention problems and ADHD
[odds ratio (OR) = 3.1; 95% CI, 1.3 to 7.2;
p = 0.01; and OR = 2.7; 95% CI, 1.2 to 5.9;
p = 0.01, respectively]. 
We did, however, observe that children
with higher prenatal and postnatal total DAPs
were at signiﬁcantly higher risk of PDD, with
an approximately 2-fold increase in risk for
each 10-fold increase in metabolites (prenatal
DAPs OR = 2.3; 95% CI, 1.0 to 5.2, p =
0.05; 24-month DAPs OR = 1.7; 95% CI,
1.0 to 2.9, p = 0.04) We observed similar sta-
tistically significant associations for prenatal
DM and 24-month DE exposures (Table 5).
The only other covariate associated with
report of PDD was maternal PPVT, which
was negatively associated with risk of PDD
(for each point increase in PPVT, OR = 0.98;
95% CI, 0.96 to 0.99; p = 0.001). 
Controlling for birth weight, gestational
age, abnormal neonatal reﬂexes, or additional
chemical exposures did not substantially
change our results. Results did not differ by sex
of the child for any of the analyses. In addition,
although we previously observed an association
with maternal DDT and 24-month MDI
(Eskenazi et al. 2006), we did not observe an
interaction between DDT and prenatal DAPs.
Overall, adjusting metabolites by creatinine
yielded results similar to primary analyses, with
some coefficients becoming slightly stronger
and some weaker. The observed negative asso-
ciation of prenatal metabolites and 24-month
MDI diminished somewhat (total DAPS: β =
–3.0; 95% CI, –6.1 to 0.1; p = 0.06; DMs: β =
–3.1; 95% CI, –5.9 to –0.4; p = 0.03).
Creatinine-adjustment of child metabolites
also reduced the positive associations of total
DAPS (β = 1.7; 95% CI, –0.3 to 3.7; p = 0.09)
and DMs (β = 1.4; 95% CI, –0.5 to 3.3; p =
0.14) on MDI at 24 months. CBCL results
changed little with creatinine adjustment. 
No signiﬁcant associations were observed
between MDA or TCPy and any Bayley or
CBCL outcomes (Table 6). 
Discussion
We have previously reported in this cohort a
relationship between DAP metabolites during
pregnancy and both shortened gestation and
poorer neonatal reflexes. These associations
were seen primarily with dimethyl phosphate
metabolites. Results from the present investiga-
tion suggest that DAP metabolite levels during
pregnancy, particularly from dimethyl phos-
phate pesticides, may be negatively associated
at 24 months with mental development (MDI)
on the Bayley Scales and an increase in risk of
maternally reported PDD. We also observed a
curious positive association of postnatal DAPs
with MDI; however, these postnatal metabo-
lites were associated with an increased risk of
PDD. Results persisted after controlling for
other chemical exposures and were indepen-
dent of previously observed associations of
shortened gestation and poorer reﬂexes. 
Although we observed associations between
neurodevelopment and DAPs, we saw no such
associations with metabolites specific to
malathion (MDA) or chlorpyrifos (TCPy).
Malathion is one of several pesticides devolving
to DMs, and chlorpyrifos is one of several pes-
ticides devolving to DEs; MDA and TCPy are
only moderately correlated with DMs and
DEs, respectively (MDA and DMs: r = 0.2 to
0.3, p < 0.001; DE and TCPy: r = 0.1 to 0.2,
p < 0.04). Thus, the observed associations with
DAPs may be attributed to compounds other
than just these two. For example, oxydemeton-
methyl, for which we cannot measure a speciﬁc
metabolite, is a widely used DM in the Salinas
Valley that is several times more neurotoxic
than malathion (Castorina et al. 2003). 
Few previous studies have examined low-
level exposure to OP pesticides and children’s
neurodevelopment using exposure biomarkers.
Direct comparison with existing studies is com-
plicated by differences in the exposure scenario
or measurements and neurodevelopmental
Eskenazi et al.
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Table 4. Adjusteda coefﬁcients (β) (95% CIs) in points on the PDI and MDI of the Bayley Scales of Infant
Development for a log10 unit increase in pesticide urinary metabolites. 
Bayley Scales of Infant Development MDIa PDIa
Total DAPs
6 months
Prenatal –1.15 (–2.89 to 0.59) –0.71 (–3.28 to 1.86)
Child –0.17 (–1.23 to 0.90) 0.39 (–1.18 to 1.97)
12 months
Prenatal –1.34 (–3.59 to 0.92) –0.60 (–3.77 to 2.57)
Child 1.36 (–0.05 to 2.78)* 1.22 (–0.78 to 3.21)
24 months
Prenatal –3.54 (–6.59 to –0.49)** –1.28 (–4.01 to 1.46)
Child 2.37 (0.50 to 4.24)# 1.06 (–0.62 to 2.74)
DMs 
6 months
Prenatal –0.95 (–2.52 to 0.62) –0.55 (–2.88 to 1.77)
Child –0.31 (–1.28 to 0.67) 0.28 (–1.17 to 1.72)
12 months
Prenatal  –1.06 (–3.12 to 0.99) –1.15 (–4.03 to 1.74)
Child  0.75 (–0.44 to 1.93) 0.46 (–1.22 to 2.13)
24 months
Prenatal –3.64 (–6.36 to –0.91)# –1.24 (–3.70 to 1.21)
Child 2.01 (0.24 to 3.78)**  1.01 (–0.58 to 2.60)
DEs 
6 months
Prenatal  –0.16 (–1.96 to 1.65) 0.02 (–2.63 to 2.67)
Child  0.24 (–0.78 to 1.25) 0.60 (–0.89 to 2.09)
12 months
Prenatal  –1.14 (–3.51 to 1.22) 0.30 (–3.03 to 3.63)
Child  1.89 (0.21 to 3.58)** 1.91 (–0.46 to 4.27)
24 months
Prenatal  –0.85 (–3.98 to 2.27) –0.86 (–3.64 to 1.92)
Child  1.02 (–0.52 to 2.57) 0.30 (–1.07 to 1.67)
aModels adjusted for psychometrician, location, exact age at assessment, sex, breast-feeding duration, HOME score,
household income above poverty threshold, parity, and maternal PPVT. *p ≤ 0.10; **p ≤ 0.05; #p ≤ 0.01.
Table 5. Adjusteda ORs (95% CIs) for syndrome scores in the clinicial (CL) or borderline clinical (BL) range
on the CBCL at 24 months of age for DAPs urinary metabolites. 
CBCL Attention (BL)a ADHD (BL)a PDD (CL)a
Total DAPs 
Prenatal  0.77 (0.27–2.24) 1.34 (0.50–3.59) 2.25 (0.99–5.16)**
Child  1.41 (0.75–2.64) 1.11 (0.61–2.03) 1.71 (1.02–2.87)**
DMs
Prenatal  0.78 (0.31–1.96) 1.27 (0.53–3.04) 2.19 (1.05–4.58)**
Child  1.54 (0.85–2.76) 1.10 (0.63–1.94) 1.52 (0.94–2.45)*
DEs 
Prenatal  0.78 (0.26–2.31) 0.59 (0.21–1.68)  0.88 (0.37–2.07)
Child 1.02 (0.61–1.71) 1.18 (0.72–1.94) 1.72 (1.12–2.64)**
aModels adjusted for sex, exact age at assessment, breast-feeding duration, HOME score, household income above
poverty threshold, parity, maternal PPVT, and maternal depression. *p ≤ 0.10; **p ≤ 0.05.assessment methods. For example, a recently
published cross-sectional study from Ecuador
lacked biomarker-based pregnancy exposures,
but DAP metabolites in 6- to 9-year-olds were
associated with increased reaction times
(Grandjean et al. 2006). In comparison, our
study was larger and longitudinal, allowing for
two pregnancy and three early childhood DAP
measurements, but we assessed different out-
comes and in younger children. Grandjean
et al. (2006) reported that their DAP levels
were similar to levels for 6- to 11-year-old U.S.
children participating in NHANES (CDC
2006). DAPs in our children were lower than
those in NHANES, but our children were con-
siderably younger than those sampled in the
national study. We observed a rise in DAPs
from 6 months to 2 years of age, which is likely
to continue as the children interact more with
their environment. As in our study, Rauh et al.
(2006) used the Bayley Scales and CBCL to
assess neurodevelopment in a cohort of chil-
dren up to 3 years of age, but measured chlor-
pyrifos, a DE pesticide, in pregnancy bloods.
Rauh et al. found inverse associations of chlor-
pyrifos with mental development and pervasive
developmental disorder, results that we found
with total DAP and DM, but not DE or
TCPy, metabolites. Unlike that study, we did
not observe associations with PDI or atten-
tional deﬁcits. However, the exposure scenario
in an agricultural community is likely quite
different from that in an urban environment.
Additionally, Rauh et al. (2006) found no
effect at 2 years of age, only at 3 years. 
We observed that DAPs in children were
positively associated with neurodevelopment.
We have no ready explanation for this ﬁnding.
One possible explanation is that children with
higher cognitive functioning may be more
interactive with their environment, leading to
higher exposure to pesticide residues. The pre-
natal measurements do not suffer from the
same issues of unknown temporal order in
that they clearly preceded the measures of
child development. Another possibility is that
children who eat more fruits and vegetables
may have higher DAP levels, but because of
better diets have higher functioning. 
DAP metabolites are limited as biomarkers
of exposure. Recent studies suggest that urinary
metabolite levels may reﬂect exposure not only
to OP parent compounds, but also to the
potentially less toxic ambient metabolites (Lu
et al. 2005). Also, because exposure to OPs
varies considerably from day to day, DAPs
from spot urine samples may not represent
average exposure over time. Although we
observed signiﬁcant correlations between some
DAP measures over time, these correlations
were weak. Preliminary results from our Center
indicate that children’s DAP measurements
more than a few days apart are uncorrelated,
suggesting considerable intraperson variability
(A. Bradman, personal communication). Any
measurement of OPs in urine or blood reﬂect
exposure during the brief (usually < 48 hr)
antecedent period and therefore may not accu-
rately reflect exposure throughout the entire
critical period of neurodevelopment. While
adjustment for creatinine muted the positive
associations we observed with child metabo-
lites and 24-month MDI, such an adjustment
warrants caution. Although widely accepted in
occupational studies of nonpregnant adults,
creatinine adjustment may not be appropriate
for metabolite levels in populations undergo-
ing rapid physiologic changes, such as preg-
nant women and young children, due to high
intraindividual variability in creatinine excre-
tion (Boeniger et al. 1993).
Another limitation of this study is that we
conducted many analyses and did not adjust
for multiple comparisons. However, because
of the interrelationships among the exposures
and among the outcomes, the comparisons
we made were not entirely independent.
Speciﬁcally, the urinary DM and DE metabo-
lites are subsets of the total DAPs and are there-
fore highly correlated with total DAPs at each
time (DAPs and DMs: r = 0.9 to 0.96. p <
0.001; DAPs and DEs: r = 0.6 to 0.7. p <
0.001). In addition, MDI and PDI were mod-
erately correlated at each of the three time
points (r = 0.3–0.5; p < 0.001) and, although
not as strongly, across ages (r = 0.1–0.2; p <
0.01), and the three CBCL outcomes we con-
sidered were associated with one another (chi-
square p < 0.001 for all combinations). Thus, a
Bonferroni correction might be considered
unduly conservative (Bland and Altman 1995).
This study also has a number of strengths.
Because children, especially those from eco-
nomically impoverished environments, may
be exposed to other environmental agents, we
collected extensive information about addi-
tional environmental exposures and measured
many with biomarkers, including lead, OC
pesticides, and PCBs. We previously found
that the CHAMACOS mothers had high
serum levels of certain OCs, such as DDT and
DDE, because many women had originated
from Mexico where these pesticides were used
more recently (Bradman et al. 2006). We have
determined in our population that both the
previously reported association of maternal
DDT with MDI (Eskenazi et al. 2006) and
the present association of maternal DAPs with
MDI persisted when these exposures were
modeled simultaneously. 
Because our population was also relatively
homogeneous, we could eliminate the poten-
tial for other covariates to explain the
observed associations. Yet because the
CHAMACOS population consisted mostly of
children from low-income families, they were
already at risk for poorer neurodevelopment
(Black et al. 2000). Although we observed
< 5% with MDI scores < 85 at 6 and 12
months of age, at 2 years of age almost 50%
showed possible deficits. Although this drop
in scores at 24 months might be attributed to
a lack of developmentally stimulating envi-
ronments, it is also possible that the Bayley
Organophosphate pesticides and neurodevelopment
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Table 6. Adjusteda coefﬁcients (β) (95% CIs) in points on the MDI and PDI of the Bayley Scales for prenatal
urinary metabolites speciﬁc to malathion (MDA) and chlorpyrifos (TCPy).
Bayley Scales of Infant Development MDIa PDIa
MDA
6 months
< LOD (reference) — —
< Median detected 0.98 (–0.85 to 2.81) 0.42 (–2.34 to 3.18)
≥ Median detected –0.25 (–2.10 to 1.60) –1.45 (–4.21 to 1.32)
12 months
< LOD (reference) — —
< Median detected  0.95 (–1.55 to 3.46) –0.53 (–4.05 to 3.00)
≥ Median detected 2.40 (–0.13 to 4.94) 0.75 (–2.81 to 4.31)
24 months
< LOD (reference) — —
< Median detected  –1.09 (–4.51 to 2.32) –0.73 (–3.87 to 2.41)
≥ Median detected 0.24 (–3.03 to 3.52) 0.33 (–2.68 to 3.35)
TCPy
6 months
< LOD (reference) — —
< Median detected 0.24 (–2.12 to 2.60) –0.56 (–4.03 to 2.91)
≥ Median detected 0.08 (–2.29 to 2.44) –0.21 (–3.69 to 3.27)
12 months
< LOD (reference) — —
< Median detected –0.45 (–3.67 to 2.76) –0.70 (–5.26 to 3.86)
≥ Median detected –0.65 (–3.88 to 2.58) –1.62 (–6.20 to 2.96)
24 months
< LOD (reference) — —
< Median detected –1.02 (–5.34 to 3.31) –2.65 (–6.50 to 1.21)
≥ Median detected –1.94 (–6.26 to 2.37) –2.72 (–6.57 to 1.12)
aModels adjusted for psychometrician, location, exact age at assessment, sex, breast-feeding duration, HOME score,
household income above poverty threshold, parity, and maternal PPVT.Scales, although having internal validity in
our population, may not be a clinically valid
tool in Spanish or in Latino immigrant com-
munities. Similar findings of drops in MDI
scores at 24 months of age have been seen in a
cross-sectional study of children in semiurban
Mexico (Fernald et al. 2006) and in African-
American and Dominican children in New
York City (Rauh et al. 2006). The proportion
of children with delays may decrease as they
are exposed to more enriched environments
such as preschool. 
We also observed a very high proportion of
CHAMACOS children with PDD. Although
DSM-oriented scales based on maternal report
are not directly equivalent to a DSM diagnosis
(Achenbach and Rescorla 2000), this high
report of PDD merits further investigation and
follow-up, especially in light of a recent study
that hypothesized that OP exposure during
critical prenatal periods of neuronal migration
may precipitate autism in a genetically vulnera-
ble population (D’Amelio et al. 2005). In a
case–control study of autism, D’Amelio et al.
(2005) reported a significant association
among Caucasian Americans between autism
and certain variants of the paraoxonase gene
(PON1) that encodes the enzyme responsible
for OP detoxiﬁcation. Thus, in future investi-
gations, we will examine the interaction
between OP exposure and PON1 gene variants
and enzyme expression on the observed associ-
ations with PDD (Furlong et al. 2006;
Holland et al. 2006). Follow-up studies of this
cohort as they enter school will determine the
clinical significance and persistence of the
observed deficits and may shed light on the
positive relationships with postnatal exposure
measurements. 
In summary, we report an adverse associa-
tion of prenatal organophosphate pesticide
exposure as measured by DAPs with mental
development and pervasive developmental
problems at 24 months of age. This study is
one of the ﬁrst to examine the associations of
both prenatal and postnatal organophosphate
exposure on early neurodevelopment. The neg-
ative associations of pregnancy DAP measures
with mental development should be inter-
preted with caution given the positive postna-
tal relationships we observed and should be
replicated in other populations.
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